Gianfranco Maffei

Prof. Dr. Gianfranco Maffei

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2023 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
Maria Elisabetta BaldassarreMaria Elisabetta Baldassarre
Maria Elisabetta Baldassarre
Daniela LoconsoleDaniela Loconsole
Daniela Loconsole
FCFrancesca Centrone
Francesca Centrone
DCDésirée Caselli
Désirée Caselli
BMBaldassarre Martire
Baldassarre Martire
Nicola LaforgiaNicola Laforgia
Nicola Laforgia
Background: Bronchiolitis is a major cause of hospitalization in infants, particularly in the first six months of life, with approximately 60–80% of admissions due to respiratory syncytial virus (RSV) infection. Currently, no prophylactic options are available for healthy infants. The present study aimed at describing the demographic, clinical, and epidemiological characteristics of infants hospitalized for bronchiolitis in the Apulia region of Italy in 2021. Methods: From January to December 2021, data on children aged 0–12 months admitted for bronchiolitis in nine neonatal or pediatric units covering 61% of pediatric beds of hospitals in the Apulia region of Italy were analyzed. Demographic data, comorbidities, need for oxygen support, length of hospital stay, palivizumab administration, and outcomes were collected. For the purpose of the analysis, patients were divided into those aged 0–3 months and > 3 months. A multivariate logistic regression model was used to explore associations between the need for oxygen support and sex, age, comorbidities, history of prematurity, length of hospital stay, and palivizumab administration. Results: This study included 349 children aged 0–12 months admitted for bronchiolitis, with a peak of hospitalization in November (7.4 cases/1,000 children). Of these patients, 70.5% were RSV positive, 80.2% were aged 0–3 months, and 73.1% required oxygen support. Moreover, 34.9% required observation in the sub-intensive care unit, and 12.9% in the intensive care unit. Of the infants who required intensive care, 96.9% were aged 0–3 months and 78.8% were born at term. Three patients required mechanical ventilation and one, who required Extra Corporeal Membrane Oxygenation, died. Children aged 0–3 months were more likely to show dyspnea, need oxygen support, and have a longer hospital stay. Conclusions: The present study showed that almost all of the children who required intensive care support were aged ≤ 3 months and most were born at term. Therefore, this age group remains the highest risk group for severe bronchiolitis. Preventive measures such as single-dose monoclonal antibody immunoprophylaxis, and maternal and childhood vaccination against RSV, may reduce the high public health burden of bronchiolitis.

6 September 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
FLAVIA INDRIOFLAVIA INDRIO
FLAVIA INDRIO
ASAlessia Salatto
Alessia Salatto
OAOrsola Amato
Orsola Amato
FBFabio Bartoli
Fabio Bartoli
LCLetizia Capasso
Letizia Capasso
Arianna AcetiArianna Aceti
Arianna Aceti

11 April 2019 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
ONon Behalf of Neonatal Pneumology Study Group Italian Society of Neonatology
on Behalf of Neonatal Pneumology Study Group Italian Society of Neonatology
FPFlavia Petrillo
Flavia Petrillo
CGCamilla Gizzi
Camilla Gizzi
GMGianfranco Maffei
Gianfranco Maffei
PMPiero G. Matassa
Piero G. Matassa
GVGiovanni Vento
Giovanni Vento
We aimed to survey Delivery Room and Neonatal Intensive Care Unit (NICU) respiratory strategies dedicated to the extremely low gestational age newborn (ELGAN – GA < 28 wks) in Italy. A questionnaire was sent to 113 Italian level III centres. A lead physician and a nurse with expertise in mechanical ventilation (MV) were identified in each unit to answer. Information about those aspects of ventilatory support considered by center’s staff as needing improvement was also collected. A 100% response rate was obtained. In the Delivery Room, sustained lung inflation was performed in 74.8% of centres, and 89.2% used NCPAP. For ELGANs who need invasive MV, conventional MV was the most used strategy. Volume-targeted ventilation and High-frequency oscillatory ventilation (HFOV) were considered as primary mode in < 30% of centres. Among non-invasive strategies, NCPAP was the most utilized, followed by BiPAP, High-flow nasal cannula and nasal intermittent positive pressure ventilation. Nurses more commonly recorded in the nursing charts the ventilator’s setting parameters rather than measured ones. HFOV and non-invasive ventilation were the most quoted aspects of neonatal ventilation felt as to be improved. The routine respiratory support practices in Italy showed marked variations among units. Focused interventions are largely required to improve clinical practice.

1 January 2006 in Journal of Perinatal Medicine
Verified
Journal Article
Closed access
GMGianfranco Maffei
Gianfranco Maffei
MRMatteo Rinaldi
Matteo Rinaldi
GRGiuseppe Rinaldi
Giuseppe Rinaldi

1 January 2008 in Journal of Perinatal Medicine
Verified
Journal Article
Closed access
GMGianfranco Maffei
Gianfranco Maffei
LMLuciano Magaldi
Luciano Magaldi
PCPasquale Cassano
Pasquale Cassano
MCMichele Cassano
Michele Cassano
ACAdolfo Cella
Adolfo Cella
RMRosario Magaldi
Rosario Magaldi

2 July 2024 in Trials
Verified
Journal Article
Open access
GVGiovanni Vento
Giovanni Vento
APAngela Paladini
Angela Paladini
CAC. Aurilia
C. Aurilia
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
VCV. P. Carnielli
V. P. Carnielli
EZE. Zannin
E. Zannin
Background: Surfactant is a well-established therapy for preterm neonates affected by respiratory distress syndrome (RDS). The goals of different methods of surfactant administration are to reduce the duration of mechanical ventilation and the severity of bronchopulmonary dysplasia (BPD); however, the optimal administration method remains unknown. This study compares the effectiveness of the INtubate-RECruit-SURfactant-Extubate (IN-REC-SUR-E) technique with the less-invasive surfactant administration (LISA) technique, in increasing BPD-free survival of preterm infants. This is an international unblinded multicenter randomized controlled study in which preterm infants will be randomized into two groups to receive IN-REC-SUR-E or LISA surfactant administration. Methods: In this study, 382 infants born at 24+0–27+6 weeks’ gestation, not intubated in the delivery room and failing nasal continuous positive airway pressure (nCPAP) or nasal intermittent positive pressure ventilation (NIPPV) during the first 24 h of life, will be randomized 1:1 to receive IN-REC-SUR-E or LISA surfactant administration. The primary outcome is a composite outcome of death or BPD at 36 weeks’ postmenstrual age. The secondary outcomes are BPD at 36 weeks’ postmenstrual age; death; pulse oximetry/fraction of inspired oxygen; severe intraventricular hemorrhage; pneumothorax; duration of respiratory support and oxygen therapy; pulmonary hemorrhage; patent ductus arteriosus undergoing treatment; percentage of infants receiving more doses of surfactant; periventricular leukomalacia, severe retinopathy of prematurity, necrotizing enterocolitis, sepsis; total in-hospital stay; systemic postnatal steroids; neurodevelopmental outcomes; and respiratory function testing at 24 months of age. Randomization will be centrally provided using both stratification and permuted blocks with random block sizes and block order. Stratification factors will include center and gestational age (24+0 to 25+6 weeks or 26+0 to 27+6 weeks). Analyses will be conducted in both intention-to-treat and per-protocol populations, utilizing a log-binomial regression model that corrects for stratification factors to estimate the adjusted relative risk (RR). Discussion: This trial is designed to provide robust data on the best method of surfactant administration in spontaneously breathing preterm infants born at 24+0–27+6 weeks’ gestation affected by RDS and failing nCPAP or NIPPV during the first 24 h of life, comparing IN-REC-SUR-E to LISA technique, in increasing BPD-free survival at 36 weeks’ postmenstrual age of life. Trial registration: ClinicalTrials.gov NCT05711966. Registered on February 3, 2023.